1. Home
  2. TNGX vs SDA Comparison

TNGX vs SDA Comparison

Compare TNGX & SDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • SDA
  • Stock Information
  • Founded
  • TNGX 2014
  • SDA 2007
  • Country
  • TNGX United States
  • SDA China
  • Employees
  • TNGX N/A
  • SDA N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • SDA Blank Checks
  • Sector
  • TNGX Health Care
  • SDA Finance
  • Exchange
  • TNGX Nasdaq
  • SDA Nasdaq
  • Market Cap
  • TNGX 317.4M
  • SDA 282.4M
  • IPO Year
  • TNGX N/A
  • SDA N/A
  • Fundamental
  • Price
  • TNGX $1.14
  • SDA $2.59
  • Analyst Decision
  • TNGX Strong Buy
  • SDA
  • Analyst Count
  • TNGX 7
  • SDA 0
  • Target Price
  • TNGX $12.33
  • SDA N/A
  • AVG Volume (30 Days)
  • TNGX 532.3K
  • SDA 148.6K
  • Earning Date
  • TNGX 05-12-2025
  • SDA 04-28-2025
  • Dividend Yield
  • TNGX N/A
  • SDA N/A
  • EPS Growth
  • TNGX N/A
  • SDA N/A
  • EPS
  • TNGX N/A
  • SDA N/A
  • Revenue
  • TNGX $42,069,000.00
  • SDA $441,897,000.00
  • Revenue This Year
  • TNGX N/A
  • SDA $65,188.29
  • Revenue Next Year
  • TNGX N/A
  • SDA N/A
  • P/E Ratio
  • TNGX N/A
  • SDA N/A
  • Revenue Growth
  • TNGX 15.17
  • SDA 21.48
  • 52 Week Low
  • TNGX $1.11
  • SDA $2.41
  • 52 Week High
  • TNGX $12.02
  • SDA $11.74
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 36.06
  • SDA 28.78
  • Support Level
  • TNGX $1.03
  • SDA $2.58
  • Resistance Level
  • TNGX $1.56
  • SDA $2.90
  • Average True Range (ATR)
  • TNGX 0.15
  • SDA 0.24
  • MACD
  • TNGX -0.01
  • SDA 0.07
  • Stochastic Oscillator
  • TNGX 17.74
  • SDA 18.37

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About SDA SunCar Technology Group Inc.

SunCar Technology Group Inc is a provider of digitalized enterprise automotive after-sales services and online auto insurance intermediation service in China. It operates an automotive after-sales services business through offering customized service solutions to enterprise clients, who are major banks, insurance companies, telecommunication companies, new energy vehicle, original equipment manufacturers or any client who have end customers demanding automotive services.

Share on Social Networks: